Nonclinical cardiovascular safety of pitolisant: comparing International Conference on Harmonization S7B and Comprehensive in vitro Pro-arrhythmia Assay initiative studies-Reference-Cited by-同舟云学术

Nonclinical cardiovascular safety of pitolisant: comparing International Conference on Harmonization S7B and Comprehensive in vitro Pro-arrhythmia Assay initiative studies

Published:2017-10-19 Issue:23 Volume:174 Page:4449-4463
ISSN:0007-1188
Container-title:British Journal of Pharmacology
language:en
Short-container-title:British Journal of Pharmacology

Author:

Ligneau Xavier¹^ORCID,Shah Rashmi R²^ORCID,Berrebi-Bertrand Isabelle¹,Mirams Gary R³^ORCID,Robert Philippe¹,Landais Laurent¹,Maison-Blanche Pierre⁴,Faivre Jean-François⁵,Lecomte Jeanne-Marie¹,Schwartz Jean-Charles¹

Affiliation:

1. Bioprojet-Biotech; Saint-Grégoire France

2. Pharmaceutical Consultant; Gerrards Cross UK

3. Centre for Mathematical Medicine and Biology, School of Mathematical Sciences; University of Nottingham; Nottingham UK

4. Hôpital Bichat; Paris France

5. Laboratoire Signalisation et Transports Ioniques Membranaires; Université de Poitiers-CNRS; Poitiers France

Funder

Royal Society

Wellcome Trust

Publisher

Wiley

Subject

Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bph.14047/fullpdf

Reference54 articles.

1. The Concise Guide to PHARMACOLOGY 2015/16: G protein-coupled receptors;Alexander;Br J Pharmacol,2015a

2. The Concise Guide to PHARMACOLOGY 2015/16: Voltage-gated ion channels;Alexander;Br J Pharmacol,2015b

3. The role of late INa in development of cardiac arrhythmias;Antzelevitch;Handb Exp Pharmacol,2014

4. Mexiletine prevents recurrent torsades de pointes in acquired long QT syndrome refractory to conventional measures;Badri;J Am Coll Cardiol EP,2015

5. Comprehensive translational assessment of human-induced pluripotent stem cell derived cardiomyocytes for evaluation drug-induced arrhythmias;Blinova;Toxicol Sci,2017

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. MORE IS DIFFERENT: DRUG PROPERTY ANALYSIS ON CELLULAR HIGH-CONTENT IMAGES USING DEEP LEARNING;2023-04-10

2. Safety of pitolisant: a study in the WHO international pharmacovigilance database;European Journal of Clinical Pharmacology;2023-03-09

3. Use of Human iPSC-CMs in Nonclinical Regulatory Studies for Cardiac Safety Assessment;Toxicological Sciences;2022-09-13

4. Clinical characteristics of a large cohort of patients with narcolepsy candidate for pitolisant: a cross-sectional study from the Italian PASS Wakix® Cohort;Neurological Sciences;2022-06-25

5. pitolisant, a novel histamine-3 receptor competitive antagonist, and inverse agonist, in the treatment of excessive daytime sleepiness in adult patients with narcolepsy;Health Psychology Research;2022-05-30